The first patient was dosed in the Phase 1 ZOLAR 7 trial of TLX300-CDx ( 89 Zr-olaratumab), which aims to validate the use of olaratumab, an antibody exclusively licensed from Eli Lilly and Company ...

Here’s how it works. iOS 18.5, currently available as a beta, isn't a massive update for Apple's iPhone software. Instead, ...

Giant Danish owner AP Moller-Maersk’s shares have been downgraded to “sell” by analysts against a “bleak” backdrop for ...

“We see risk of negative volume growth from the second half of 2025, especially if we see more front-loading from the 90-day ...

Community health centers (CHCs) have traditionally enjoyed bipartisan support: they provide high-quality, cost-effective care ...

NEW YORK, NY / ACCESS Newswire / April 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sempra ...